Skip to content
healthcare.dev

Actonel

NDC 0430-0472, Risedronate Sodium, tablet, film coated, from Allergan, Inc..

Product NDC
0430-0472
Status
Listed
Labeler
Allergan, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020835
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0430-0472 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM HEMIPENTAHYDRATE30.1 mg/1
  • RISEDRONATE SODIUM MONOHYDRATE4.9 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Bisphosphonate [EPC]; Diphosphonates [CS]; Diphosphonates [CS]

Package NDCNDC-11Package
0430-0472-03004300472034 TABLET, FILM COATED in 1 DOSE PACK (0430-0472-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/24ed00e0-25e2-49a8-97fc-66c1b417dc0b
  • NADAC price for package 00430047203

    GET /v1/drugs/nadac/00430047203

Use it

Look up 0430-0472 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0430-0472 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0430-0472. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.